Edgewise Therapeutics, Inc.’s EWTX share price has surged by 7.97%, which has investors questioning if this is right time to sell.

Edgewise Therapeutics, Inc.’s EWTX share price has dipped by 15.24%, which has investors questioning if this is right time to ...

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks ...

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other stocks that insiders bought in April after Trump’s tariff rollout.

Hinterhaus Productions via Getty Images Shares of Edgewise Therapeutics fell sharply Wednesday after the company released data for its latest clinical trial. The drug accomplished its main goal ...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) – Research analysts at Wedbush decreased their Q1 2025 earnings estimates for shares of Edgewise Therapeutics in a research note issued ...

April 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced positive top-line data of EDG-7500 from the Phase 2 ...

In this article, we are going to take a look at where Edgewise Therapeutics, Inc. (NASDAQ:EWTX) stands against other unstoppable stocks that could double your money. Generating significant returns ...

The last time I wrote about Edgewise Therapeutics, Inc. (NASDAQ:EWTX) it was in a Seeking Alpha article entitled "Edgewise: Remains A Buy After Latest Becker Muscular Dystrophy Data." In the ...

Shares of Edgewise Therapeutics EWTX plunged 47.7% in a week, likely due to safety concerns for its investigational candidate, EDG-7500, in patients with obstructive or nonobstructive hypertrophic ...

BOULDER, Colo., April 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. (EWTX), a leading muscle disease biopharmaceutical company, today announced the pricing of an underwritten offering of ...